Dosimetry
In both parts A and B of the study, patients underwent planar whole-body imaging at 4 h, and on days 1, 2, 3, and 6 after each [To assure patient safety, patient-specific dosimetry calculations were performed for organs-at-risk (kidney and bone marrow) after each treatment cycle in both parts A and B using the absorbed dose calculation features of the NUKDOS software [